Punjab, April 27 -- LONDON, April 27, 2026 /PRNewswire/ - Concept Medical Inc., today announced the presentation of preliminary 3-year follow-up data from the SIRONA randomised trial at the Charing Cross (CX) Symposium 2026, reinforcing its leadership in drug-delivery technologies for peripheral interventions. The data were presented by Principal Investigator Prof. Ulf Teichgraber during a podium first session on '3-year results from the SIRONA randomised trial.'SIRONA is a randomised controlled trial evaluating sirolimus-coated versus paclitaxel-coated balloon angioplasty in femoropopliteal artery disease, designed to generate robust head-to-head comparative evidence in a field historically dominated by paclitaxel-based therapies. Previous...